FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4548411000001109: Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26672101000001118 Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26672201000001113 Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Is a Primidone 250mg/5ml oral suspension 250 ml true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Is pack of Mysoline 250mg/5ml oral suspension (Zeneca Pharma) false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has active ingredient Primidone false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml VMP prescribing status (attribute) VMP invalid as a prescribable product false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has AMP Mysoline 250mg/5ml oral suspension (Zeneca Pharma) true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has specific active ingredient Primidone true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start